Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Health Resource Utilization and Costs Associated with the Use of Obinutuzumab-Based Regimens Are Similar to Rituximab-Based Regimens for the First-Line Treatment of Follicular Lymphoma

Tu My To, PhD, Keith L. Dawson, DNP, MS, Anthony S Masaquel, PhD MPH, Arpamas Seetasith, PhD

Blood (2019) 134 (Supplement_1): 4721.

https://doi.org/10.1182/blood-2019-123408

Published: 2019

Journal Articles

Successful Outcomes Of An Infant Sickle Cell Clinic In Luanda, Angola

Patrick T. McGann, MD, Margarida Muhongo, Elizabeth McGann, Vysolela de Oliveira, Brigida Santos, MD, Russell E. Ware, MD, PhD

Blood (2013) 122 (21): 2934.

https://doi.org/10.1182/blood.V122.21.2934.2934

Published: 2013

Journal Articles

Compliance with Imatinib Mesylate Associated with Lower Health Resource Utilization and Costs for Patients with CML and GIST.

Rachel Halpern, PhD, Victoria Barghout, MSPH, Denise Williams, MD

Blood (2007) 110 (11): 5159.

https://doi.org/10.1182/blood.V110.11.5159.5159

Published: 2007

Journal Articles

Acceptability and Validity of Use of a Patient-Reported Cost Diary To Capture Health Resource Utilization and Costs Associated with Deep Venous Thrombosis and Post-Thrombotic Syndrome.

Wissam El-Hadi, BSc, Thierry Ducruet, MSc, Mira Johri, PhD, Susan R. Kahn, MD FRCPC MSc

Blood (2007) 110 (11): 5173.

https://doi.org/10.1182/blood.V110.11.5173.5173

Published: 2007

Journal Articles

A Multidisciplinary Care Management Program for Patients with Sickle Cell Syndromes Significantly Reduces Health Care Resource Utilization.

William S. Jonas, MD, Matthew Hogan, MD, Allan F. Platt, PA, Melanie Jacob, MD, JoAnn A. Beasley, RN, Philip Lamson, Sheila Palmer, PA, Hanna J. Khoury, MD, James R. Eckman, MD

Blood (2005) 106 (11): 1339.

https://doi.org/10.1182/blood.V106.11.1339.1339

Published: 2005

NARROW

Health Resource Utilization and Costs Associated with the Use of Obinutuzumab-Based Regimens Are Similar to Rituximab-Based Regimens for the First-Line Treatment of Follicular Lymphoma

Successful Outcomes Of An Infant Sickle Cell Clinic In Luanda, Angola

Compliance with Imatinib Mesylate Associated with Lower Health Resource Utilization and Costs for Patients with CML and GIST.

Acceptability and Validity of Use of a Patient-Reported Cost Diary To Capture Health Resource Utilization and Costs Associated with Deep Venous Thrombosis and Post-Thrombotic Syndrome.

A Multidisciplinary Care Management Program for Patients with Sickle Cell Syndromes Significantly Reduces Health Care Resource Utilization.

Email alerts

ASH Publications

American Society of Hematology

Health Resource Utilization and Costs Associated with the Use of Obinutuzumab-Based Regimens Are Similar to Rituximab-Based Regimens for the First-Line Treatment of Follicular Lymphoma

Successful Outcomes Of An Infant Sickle Cell Clinic In Luanda, Angola

Compliance with Imatinib Mesylate Associated with Lower Health Resource Utilization and Costs for Patients with CML and GIST.

Acceptability and Validity of Use of a Patient-Reported Cost Diary To Capture Health Resource Utilization and Costs Associated with Deep Venous Thrombosis and Post-Thrombotic Syndrome.

A Multidisciplinary Care Management Program for Patients with Sickle Cell Syndromes Significantly Reduces Health Care Resource Utilization.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only